Cited by 375Cytokine Signaling Pathways and InteractionsProtein Tyrosine PhosphatasesGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

STAT3β, a Splice Variant of Transcription Factor STAT3, Is a Dominant Negative Regulator of Transcription

Open access

Caldenhoven, Eric, van Dijk, Thamar B., Solari, Roberto, Armstrong, John, Raaijmakers, Jan A.M., Lammers, Jan-Willem J., Koenderman, Leo, de Groot, Rolf P.·1996·Journal of Biological Chemistry

DOI 10.1074/jbc.271.22.13221

Open this paper in CoChat — free account

Abstract

The 89-kDa STAT3 protein is a latent transcription factor which is activated in response to cytokines (interleukin (IL)-5 and -6) and growth factors (epidermal growth factor). Binding of IL-5 to its specific receptor activates JAK2 which leads to the tyrosine phosphorylation of STAT3 proteins. Here we report the cloning of a cDNA encoding a variant of the transcription factor STAT3 (named STAT3beta) which was isolated by screening an eosinophil cDNA library. Compared to wild-type STAT3, STAT3beta lacks an internal domain of 50 base pairs located near the C terminus. This splice product is a naturally occurring isoform of STAT3 and encodes a 80-kDa protein. We found by reconstitution of the human IL-5R in COS cells that like STAT3, STAT3beta is phosphorylated on tyrosine and binds to the pIRE from the ICAM-1 promoter after IL-5 stimulation. However, STAT3beta fails to activate a pIRE containing promoter in transient transfection assays. Instead, co-expression of STAT3beta inhibits the transactivation potential of STAT3. These results suggests that STAT3beta functions as a negative regulator of transcription.

Integrity signals

Registry

Crossref · 10.1074/jbc.271.22.13221

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling
Hunter, T. R. (1995) · Cell · doi:10.1016/0092-8674(95)90405-0 · Cited by 2,961
Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis
Fried, M. G., & Crothers, D. M. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.23.6505 · Cited by 2,658
Stat3: a STAT Family Member Activated by Tyrosine Phosphorylation in Response to Epidermal Growth Factor and Interleukin-6
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Differentiation and proliferation of hematopoietic stem cells
Ogawa, M. (1993) · Blood · doi:10.1182/blood.v81.11.2844.2844 · Cited by 1,383
CYTOKINES: COORDINATORS OF IMMUNE AND INFLAMMATORY RESPONSES
Arai, K., Lee, F., Miyajima, A., Miyatake, S., Arai, N., & Yokota, T. (1990) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.59.070190.004031 · Cited by 1,318
A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the sam mRNA
Descombes, P., & Schibler, U. (1991) · Cell · doi:10.1016/0092-8674(91)90531-3 · Cited by 977
Jaks and Stats in signaling by the cytokine receptor superfamily.
Ihle, J., & Kerr, I. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89000-9 · Cited by 953

Flagged first, then by citations

Show all 61 references

Research works printed but not linked: 8

Wegenka, 1994, Mol. Cell. Biol., 14, 3186
Yamamoto, 1994, Mol. Cell. Biol., 14, 4342
Kuang, 1993, Mol. Cell. Biol., 13, 2536
Quelle, 1994, Mol. Cell. Biol., 14, 4335
Zanders, 1994, Eur. Cytokine Network, 5, 35
Graham, 1973, Mol. Cell. Biol., 2, 607
Brasier, 1989, BioTechniques, 7, 1116
Truss, 1993, Endocr. Rev., 14, 459

Sorted by citations

STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
STATs in oncogenesis
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Signaling through the JAK/STAT pathway, recent advances and future challenges
Kisseleva, T., Bhattacharya, S., Braunstein, J., & Schindler, C. (2002) · Gene · doi:10.1016/s0378-1119(02)00398-0 · Cited by 1,170
Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,036
Serine phosphorylation of STATs
Decker, T., & Kovarik, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203481 · Cited by 887
Three-dimensional structure of the Stat3β homodimer bound to DNA
Becker, S., Groner, B., & Müller, C. W. (1998) · Nature · doi:10.1038/28101 · Cited by 802
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro‐Cacho, C., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S. J., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Chen, X., Yao, Q., Gu, X., Shi, Q., Yuan, X., Chu, Q., Bao, Z., Lu, J., & Li, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01468-7 · Cited by 797
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
Self-citation
The Jak-STAT pathway
Imada, K., & Leonard, W. J. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(00)00018-3 · Cited by 610
Activation of the JAK-STAT pathway by reactive oxygen species
Simon, A. R., Rai, U., Fanburg, B. L., & Cochran, B. (1998) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1998.275.6.c1640 · Cited by 597
STAT proteins: novel molecular targets for cancer drug discovery
Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1204086 · Cited by 643
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Biology and significance of the JAK/STAT signalling pathways
Kiu, H., & Nicholson, S. E. (2012) · Growth Factors · doi:10.3109/08977194.2012.660936 · Cited by 470
SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling
Emanuelli, B., Peraldi, P., Filloux, C., Sawka‐Verhelle, D., Hilton, D. J., & OBBERGHEN, E. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15985 · Cited by 468
Pre-mRNA splicing in disease and therapeutics
Singh, R. K., & Cooper, T. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.06.006 · Cited by 472
β4 Integrin Amplifies ErbB2 Signaling to Promote Mammary Tumorigenesis
Guo, W., Pylayeva, Y., Pepe, A., Yoshioka, T., Muller, W. J., Inghirami, G., & Giancotti, F. G. (2006) · Cell · doi:10.1016/j.cell.2006.05.047 · Cited by 466
Signaling mechanisms through gp130: A model of the cytokine system
Hirano, T., Nakajima, K., & Hibi, M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(98)80005-1 · Cited by 375
The myocardial JAK/STAT pathway: From protection to failure
Boengler, K., Hilfiker‐Kleiner, D., Drexler, H., Heusch, G., & Schulz, R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.08.002 · Cited by 373
GAS Elements: A Few Nucleotides with a Major Impact on Cytokine-Induced Gene Expression
DECKER, T., KOVARIK, P., & MEINKE, A. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.121 · Cited by 437
Structure, function, and regulation of STAT proteins
Lim, C. P., & Cao, X. (2006) · Molecular BioSystems · doi:10.1039/b606246f · Cited by 371
Signal transducer and activator of transcription proteins in leukemias
Beneklı, M., Baer, M. R., Baumann, H., & Wetzler, M. (2003) · Blood · doi:10.1182/blood-2002-04-1204 · Cited by 336
Surgically induced leukocytic infiltrates within the rat intestinal muscularis mediate postoperative ileus
Kalff, J. C., Carlos, T. M., Schraut, W. H., Billiar, T. R., Simmons, R. L., & Bauer, A. J. (1999) · Gastroenterology · doi:10.1053/gast.1999.0029900378 · Cited by 323
The Jak-Stat pathway in normal and perturbed hematopoiesis
Ward, A. C., Touw, I. P., & Yoshimura, A. (2000) · Blood · doi:10.1182/blood.v95.1.19.001k34_19_29 · Cited by 320
Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo.
Niu, G., Heller, R. F., Catlett-Falcone, R., Coppola, D., Jaroszeski, M. J., Dalton, W. S., Jove, R., & Yu, H. (1999) · PubMed · Cited by 313
Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling
Sinibaldi, D., Wharton, W., Turkson, J., Bowman, T. L., Pledger, W. J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203947 · Cited by 290
Negative regulation of the JAK/STAT pathway
Starr, R., & Hilton, D. J. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199901)21:1 · Cited by 287
The Structure, Regulation and Function of the Janus Kinases (JAKs) and the Signal Transducers and Activators of Transcription (STATs)
Pellegrini, S., & Dusanter‐Fourt, I. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00615.x · Cited by 285
Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins
Takemoto, S., Mulloy, J. C., Cereseto, A., Migone, T.-S., Patel, B. K. R., Matsuoka, M., Yamaguchi, K., Takatsuki, K., Kamihira, S., White, J. D., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13897 · Cited by 271
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells
Burke, W. M., Jin, X., Lin, H.-J. L., Huang, M., Liu, R., Reynolds, R. K., & Lin, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204990 · Cited by 271
STAT3, stem cells, cancer stem cells and p63
Galoczová, M., Coates, P. J., & Vojtěšek, B. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0078-0 · Cited by 272
Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein
Turkson, J., Bowman, T. L., Adnane, J., Zhang, Y., Djeu, J. Y., Sekharam, M., Frank, D. A., Holzman, L. B., Wu, J., Sebti, S. M., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.11.7519 · Cited by 259
Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor κB
YU, Z., ZHANG, W., & KONE, B. C. (2002) · Biochemical Journal · doi:10.1042/bj20020588 · Cited by 255
Naturally Occurring Dominant Negative Variants of Stat5
Wang, D., Stravopodis, D. J., Teglund, S., Kitazawa, J., & Ihle, J. N. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6141 · Cited by 255
Cooperation between STAT3 and c-Jun Suppresses Fas Transcription
Ivanov, V. N., Bhoumik, A., Ma, K., Raz, R., Owen‐Schaub, L. B., Levy, D. E., Horvath, C. M., & Ronai, Z. A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00199-x · Cited by 244
Inhibition of macrophage function prevents intestinal inflammation and postoperative ileus in rodents
Wehner, S., Behrendt, F. F., Lyutenski, B. N., Lysson, M., Bauer, A. J., Hirner, A., & Kalff, J. C. (2006) · Gut · doi:10.1136/gut.2005.089615 · Cited by 249
Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation
Grimley, P. M. (1999) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00011-8 · Cited by 245
The role of STATs in myeloid differentiation and leukemia
Coffer, P. J., Koenderman, L., & de Groot, R. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203479 · Cited by 225
Self-citation
Transcriptional Activation of the p21 Gene by Interleukin-6 Type Cytokines
Bellido, T., O’Brien, C. A., Roberson, P. K., & Manolagas, S. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.33.21137 · Cited by 224
STAT3 in Cancer—Friend or Foe?
Zhang, H., & Lai, R. L. (2014) · Cancers · doi:10.3390/cancers6031408 · Cited by 219
The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer
Marabti, E. E., & Younis, I. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00080 · Cited by 224
Regulation of Proliferation, Differentiation and Survival by the IL-3/IL-5/GM-CSF Receptor Family
de Groot, R. P., Coffer, P. J., & Koenderman, L. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(98)00023-0 · Cited by 215
Self-citation
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid
Máximo, V., Botelho, T. O., Capela, J., Soares, P., Lima, J. P., Taveira, A., Amaro, T., Barbosa, A. P., Preto, A., Harach, H. R., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602547 · Cited by 215
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Debnath, B., Xu, S., & Neamati, N. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300207s · Cited by 206
Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3)
Fitzgerald, J. S., Poehlmann, T. G., Schleußner, E., & Markert, U. R. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn010 · Cited by 208
Comparison of gene expression in HCT116 treatment derivatives generated by two different 5-fluorouracil exposure protocols.
Angelis, P. M. D., Kravik, K., Tunheim, S. H., Haug, T., & Reichelt, W. H. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-11 · Cited by 205
STAT3 and epithelial–mesenchymal transitions in carcinomas
Wendt, M. K., Balanis, N. G., Carlin, C. R., & Schiemann, W. P. (2014) · JAK-STAT · doi:10.4161/jkst.28975 · Cited by 206
A splice variant of human Bmal1 acts as a negative regulator of the molecular circadian clock
Lee, J., Park, E., Kim, G. H., Kwon, I., & Kim, K. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0187-x · Cited by 200
The STAT3 isoforms α and β have unique and specific functions
Maritano, D., Sugrue, M. L., Tininini, S., Dewilde, S., Strobl, B., Fu, X., Murray-Tait, V., Chiarle, R., & Poli, V. (2004) · Nature Immunology · doi:10.1038/ni1052 · Cited by 234
Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis
Zhang, Y.-W., Wang, L., Jove, R., & Woude, G. F. V. (2002) · Oncogene · doi:10.1038/sj.onc.1205004 · Cited by 203
Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: Tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines
Nielsen, M., Kaltoft, K., Nordahl, M., Röpke, C., Geisler, C., Mustelin, T., Dobson, P., Svejgaard, A., & Ødum, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6764 · Cited by 220
Constitutive Activation of Stat 3 Oncogene Product in Human Ovarian Carcinoma Cells
Huang, M., Page, C., Reynolds, R. K., & Lin, J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5931 · Cited by 190
STAT5 Activation by BCR-Abl Contributes to Transformation of K562 Leukemia Cells
de Groot, R. P., Raaijmakers, J. A. M., Lammers, J. J., Jove, R., & Koenderman, L. (1999) · Blood · doi:10.1182/blood.v94.3.1108.415k07_1108_1112 · Cited by 188
Self-citation
Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
Beneklı, M., Xia, Z., Donohue, K. A., Ford, L. A., Pixley, L. A., Baer, M. R., Baumann, H., & Wetzler, M. (2002) · Blood · doi:10.1182/blood.v99.1.252 · Cited by 181
Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling
Kim, M., Morales, L. D., Jang, I., Cho, Y., & Kim, D. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092708 · Cited by 181
Specific DNA Binding of Stat5, but Not of Glucocorticoid Receptor, Is Required for Their Functional Cooperation in the Regulation of Gene Transcription
Stoecklin, E., Wissler, M., Moriggl, R., & Groner, B. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6708 · Cited by 173
Myocyte hypertrophy and apoptosis: a balancing act
VANEMPEL, V. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.02.013 · Cited by 167
Signal Transducers and Activators of Transcription (STATs): Novel Targets of Chemopreventive and Chemotherapeutic Drugs
Klampfer, L. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906776056491 · Cited by 169
Wilms' Tumor Gene (WT1) Competes With Differentiation-Inducing Signal in Hematopoietic Progenitor Cells
Inoue, K., Tamaki, H., Ogawa, H., Oka, Y., Soma, T., Tatekawa, T., Oji, Y., Tsuboi, A., Kim, E. H., Kawakami, M., et al. (1998) · Blood · doi:10.1182/blood.v91.8.2969.2969_2969_2976 · Cited by 169
Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells
Yang, L., Wang, L., Lin, H., Kan, P., Xie, S., Tsai, M.-Y., Wang, P., Chen, Y.-T., & Chang, C. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00792-7 · Cited by 168
Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity
Zhang, Y., Turkson, J., Carter‐Su, C., Smithgall, T. E., Levitzki, A., Kraker, A. J., Krolewski, J. J., Medveczky, P. G., & Jove, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002383200 · Cited by 166
STAT3 Phosphorylation at Tyrosine 705 and Serine 727 Differentially Regulates Mouse ESC Fates
Huang, G., Yan, H., Ye, S., Tong, C., & Ying, Q. (2013) · Stem Cells · doi:10.1002/stem.1609 · Cited by 166
Signal transducer and activator of transcription (STAT) signalling and T‐cell lymphomas
Mitchell, T. J., & John, S. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02091.x · Cited by 172
Activation of the STAT pathway in acute lung injury
Severgnini, M., Takahashi, S., Rozo, L., Homer, R., Kuhn, C., Jhung, J. W., Perides, G., Steer, M. L., Hassoun, P. M., Fanburg, B. L., et al. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00349.2003 · Cited by 165
STAT3 and its targeting inhibitors in osteosarcoma
Liu, Y., Liao, S., Bennett, S., Tang, H., Song, D., Wood, D., Zhan, X., & Xu, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12974 · Cited by 163
IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line
Dumon, S., Santos, S. C. R., Debierre-Grockiego, F., Gouilleux‐Gruart, V., Petit, L., Boucheron, C., Mollat, P., Gisselbrecht, S., & Gouilleux, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202796 · Cited by 158
Linkage between STAT Regulation and Epstein-Barr Virus Gene Expression in Tumors
Chen, H., Lee, J. M., Zong, Y., Borowitz, M. J., Ng, M. H., Ambinder, R. F., & Hayward, S. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.6.2929-2937.2001 · Cited by 163
Antitumorigenic potential of STAT3 alternative splicing modulation
Zammarchi, F., de Stanchina, E., Bournazou, E., Supakorndej, T., Martires, K., Riedel, E., Corben, A. D., Bromberg, J. F., & Cartegni, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108482108 · Cited by 176
Hdac7 promotes lung tumorigenesis by inhibiting Stat3 activation
Lei, Y., Liu, L., Zhang, S., Guo, S., Li, X., Wang, J., Su, B., Fang, Y., Chen, X., Ke, H., et al. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0736-2 · Cited by 152
Genetic Modulation of RNA Splicing with a CRISPR-Guided Cytidine Deaminase
Yuan, J., Ma, Y., Huang, T., Chen, Y., Peng, Y., Li, B., Li, J., Zhang, Y., Song, B., Sun, X., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.09.002 · Cited by 153
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation
Lehtonen, A., Matikainen, S., Miettinen, M., & Julkunen, I. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.511 · Cited by 151
A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation
Zhang, X., Sun, Y., Pireddu, R., Yang, H., Urlam, M. K., Lawrence, H. R., Guida, W. C., Lawrence, N. J., & Sebti, S. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3175 · Cited by 146
Mitochondrial Stat3, the need for design thinking
Yang, R., & Rincon, M. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.15153 · Cited by 147
Rac1 mediates STAT3 activation by autocrine IL-6
Faruqi, T. R., Gomez, D., Bustelo, X. R., Bar‐Sagi, D., & Reich, N. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161281298 · Cited by 149
Functionally Distinct Isoforms of STAT5 Are Generated by Protein Processing
Azam, M., Lee, C., Strehlow, I., & Schindler, C. (1997) · Immunity · doi:10.1016/s1074-7613(00)80445-8 · Cited by 147
Interplay between Janus Kinase/Signal Transducer and Activator of Transcription Signaling Activated by Type I Interferons and Viral Antagonism
Nan, Y., Wu, C., & Zhang, Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01758 · Cited by 146
STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer
Awasthi, N. P., Liongue, C., & Ward, A. C. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01214-y · Cited by 155
Signal Transducers and Activators of Transcription as Downstream Targets of Nongenomic Estrogen Receptor Actions
Björnström, L., & Sjöberg, M. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0072 · Cited by 149
WSSV infection activates STAT in shrimp
Chen, W. Y., Ho, K. C., Leu, J. H., Liu, K. F., Wang, H., Kou, G. H., & Lo, C. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2008.03.003 · Cited by 150
Functional Differences between Stat3α and Stat3β
Schaefer, T. S., Sanders, L. K., Park, O. K., & Nathans, D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5307 · Cited by 144
STAT3 Is a Serine Kinase Target in T Lymphocytes
Ng, J., & Cantrell, D. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24542 · Cited by 141
Etk, a Btk Family Tyrosine Kinase, Mediates Cellular Transformation by Linking Src to STAT3 Activation
Tsai, Y.-T., Su, Y., Fang, S.-S., Huang, T.-N., Qiu, Y., Jou, Y., Shih, H.-M., Kung, H.-J., & Chen, R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.2043-2054.2000 · Cited by 141
STAT5-Dependent CyclinD1 and Bcl-xL Expression in Bcr-Abl-Transformed Cells
de Groot, R. P., Raaijmakers, J. A. M., Lammers, J. J., & Koenderman, L. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0231 · Cited by 140
Self-citation
Specific ablation of Stat3β distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock
Yoo, J.-Y., Huso, D. L., Nathans, D., & Desiderio, S. (2002) · Cell · doi:10.1016/s0092-8674(02)00636-0 · Cited by 139
Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor.
Shao, H., Cheng, H. Y., Cook, R. G., & Tweardy, D. J. (2003) · PubMed · Cited by 136
Control of myeloid differentiation and survival by Stats
Smithgall, T. E., Briggs, S. D., Schreiner, S. J., Lerner, E. C., Cheng, H. Y., & Wilson, M. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203477 · Cited by 134
STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP
Spiotto, M. T., & Chung, T. D. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000201)42:2 · Cited by 133
Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3
Woetmann, A., Nielsen, M., Christensen, S. T., Brockdorff, J. L., Kaltoft, K., Engel, A., Skov, S., Brender, C., Geisler, C., Svejgaard, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10620 · Cited by 131
Cytokines and STAT Signaling
Schindler, C., & Strehlow, I. (1999) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60111-8 · Cited by 130
Interleukin-6 Signal Transduction and Lymphocyte Function
Horn, F., Henze, C., & Heidrich, K. (2000) · Immunobiology · doi:10.1016/s0171-2985(00)80061-3 · Cited by 134
Reproductive Hormone-Induced, STAT3-Mediated Interleukin 6 Action in Normal and Malignant Human Ovarian Surface Epithelial Cells
Syed, V. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.8.617 · Cited by 130
Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest.
Niu, G., Shain, K. H., Huang, M., Ravi, R. K., Bedi, A., Dalton, W. S., Jove, R., & Yu, H. (2001) · PubMed · Cited by 127
Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation
Schuringa, J.-J., Schepers, H., Vellenga, E., & Kruijer, W. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02354-7 · Cited by 124
Glucocorticoid Receptor/Signal Transducer and Activator of Transcription 5 (STAT5) Interactions Enhance STAT5 Activation by Prolonging STAT5 DNA Binding and Tyrosine Phosphorylation
Wyszomierski, S. L., Yeh, J., & Rosen, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0232 · Cited by 124
A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia
Seto, D. N., Kandarian, S. C., & Jackman, R. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.638411 · Cited by 123

Authors: Caldenhoven, E., van Dijk, T. B., Solari, R., Armstrong, J., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., & de Groot, R. P.
Affiliations: University Medical Center Utrecht (NL)
Corresponding author: de Groot, Rolf P.
ORCID: Solari, Roberto
Raaijmakers, Jan A.M.
Lammers, Jan-Willem J.
Koenderman, Leo
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 1996-05
Volume: 271
Issue: 22
Pages: 13221-13227
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.271.22.13221
OpenAlex: W1495457417
Cited by: 373
References: 61
Citations by year: 2026: 4 · 2025: 3 · 2024: 8 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 7 · 2019: 9 · 2018: 10 · 2017: 7 · 2016: 8 · 2015: 6 · 2014: 14 · 2013: 10 · 2012: 8
FWCI: 11.54
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 8934 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: Wellcome Trust
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: STAT3β, transcription factors, dominant negative regulation, IL-5 receptor, eosinophils, transactivation inhibition, cytokine signaling, epidermal growth factor
MeSH terms: Amino Acid Sequence, Animals, Base Sequence, Cell Line, Cloning, Molecular, DNA-Binding Proteins, Humans, Molecular Sequence Data, Phosphorylation, Repressor Proteins, RNA Splicing, Sequence Homology, Nucleic Acid, Transcription, Genetic, Tyrosine, Trans-Activators, DNA, Complementary, STAT3 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

STAT3β, a Splice Variant of Transcription Factor STAT3, Is a Dominant Negative Regulator of Transcription

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks